Lost time: Productivity and the flu
A new report into productivity and the flu, published by the International Longevity Centre UK (ILC), finds that the flu cost better off countries...
New insights into how flu and cold infections interact
New insights into how flu and cold infections interact have been published, finding that people were less likely to catch either influenza or a...
New research initiative to tackle multimorbidity – applications required
MRC, NIHR and ESRC are to join forces to launch an ambitious multidisciplinary research initiative to tackle multimorbidity.
Applications are sought to build a national...
New data on health outcomes and infections for private healthcare
The Private Healthcare Information Network (PHIN) has published new data on health outcomes and risk of infections for privately-funded patient healthcare in the UK. According...
How are LifeArc collaborating to advance research and science for patient benefit?
Melanie Lee CBE is Chief Executive of LifeArc, a self-funded medical research charity that is working in collaboration to translate early science for patient...
Is the NHS a commercially viable market for pharma?
Claudia Rubin, Director at Decideum, questions how long the NHS will be a commercially viable market for pharma as she looks to 2020. “If you...
Merging CCGs to align commissioning
Julie Das-Thompson, Head of Policy and Delivery at NHS Clinical Commissioners, researches how 2020 will see the merging of at least 20 clinical commissioning...
Living well with HIV and AIDS around the world
1st December is World AIDS Day which raises awareness of HIV and AIDS around the world. There have been huge leaps in the treatment...
How has 2019 shaped community pharmacies?
Deborah Evans, Managing Director of Pharmacy Complete, reflects on how 2019 has shaped the face of community pharmacy. 2019 has been an eventful year for...
How is cancer care transforming?
Oli Hudson, Content Director at Wilmington Healthcare, researches how diverse teams will work together in cancer care and transforming services in line with the...
Latest articles
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
Digital interventions for behaviour change
New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
Acute aortic dissection is a ‘ticking time bomb’
Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...
Popular articles
NICE rejects Janssen’s Stelara for moderate to severe ulcerative colitis
The National Institute for Health and Care Excellence (NICE) has not recommended ustekinumab, Janssen's Stelara, for treating moderately to severely active ulcerative colitis in...
Meningitis B infant vaccination programme shows 75% drop in cases over three years
Meningitis B infant vaccination programme shows 75% drop in cases over three years, these are the results of one of two independent meningitis B...
AstraZeneca’s Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England
The National Institute for Health and Care Excellence (NICE) has published final guidance that does not recommend AstraZeneca's Tagrisso▼ (osimertinib) for use within NHS...
Integrated commercial deployment in life sciences and other 2020 health trends
Syneos Health explore integrated commercial deployment in life sciences and discuss their new report covering 2020 health trends. Life science leaders aren’t launching with...
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...